Study on Safety and Efficacy of Two Doses of PRS CK STORM in the Modulation of the Cytokine Storm in Patients With Acute Respiratory Infection Caused by SARS-Cov-2, Influenza A, Influenza B and Respiratory Syncytial Virus (RSV)

Clinical trial NCT06684379 · RECRUITING

Trial details

NCT number: NCT06684379
Sponsor: PEACHES BIOTECH
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

SARS-CoV-2 Influenza, Human Respiratory Syncytial Virus Infections Respiratory Distress Syndrome Systemic Inflammatory Response Syndrome

Start date: 2024-10-02
Primary completion: 2026-10-02
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.